Can I Take Rhodiola with Synthroid (Levothyroxine)?

Why This Question Matters

Rhodiola rosea is one of the most popular adaptogenic herbs sold in the United States, generating over $60 million in annual retail sales according to the American Botanical Council's 2023 Herb Market Report. Many people who take levothyroxine for hypothyroidism also use rhodiola for fatigue, a symptom that persists in 10% to 15% of treated hypothyroid patients even when TSH is within range [1].

The Core Concern

The worry is straightforward: could rhodiola alter how levothyroxine is absorbed, metabolized, or used by the body? Or could it independently shift thyroid hormone levels? Answering these questions requires separating pharmacokinetic interactions (what the body does to the drug) from pharmacodynamic ones (what the drug does to the body).

What the Evidence Actually Shows

No randomized controlled trial has tested rhodiola alongside levothyroxine in humans. The Natural Medicines Comprehensive Database, which the American Pharmacists Association uses as a clinical reference, lists no direct interaction between Rhodiola rosea and levothyroxine [2]. That absence of data is not the same as confirmed safety. It means the interaction has not been studied with the rigor required to issue a formal rating.

Pharmacokinetic Considerations: Absorption and Metabolism

Levothyroxine is a narrow-therapeutic-index drug. Small changes in absorption can shift TSH by clinically meaningful amounts. The FDA's prescribing information for Synthroid warns that foods, supplements, and medications containing calcium, iron, or aluminum hydroxide can reduce levothyroxine absorption by 30% to 40% when taken concurrently [3].

Does Rhodiola Contain Absorption-Blocking Minerals?

Rhodiola rosea root does not contain pharmacologically relevant amounts of calcium, iron, or magnesium. A 2019 elemental analysis of commercial rhodiola extracts published in the Journal of AOAC International found trace mineral content well below thresholds known to interfere with T4 absorption [4]. This makes rhodiola different from supplements like calcium citrate, ferrous sulfate, or magnesium oxide, all of which require a 4-hour separation window from levothyroxine.

CYP Enzyme Effects

Levothyroxine undergoes hepatic deiodination rather than cytochrome P450-mediated metabolism, so the CYP-inhibiting or CYP-inducing properties of rhodiola are less relevant here than they would be for drugs cleared through CYP3A4 or CYP2D6. A 2014 in vitro study in Drug Metabolism and Disposition found that rhodiola extract inhibited CYP3A4 at high concentrations but had minimal effects on CYP1A2 and CYP2D6 [5]. Because levothyroxine's primary clearance pathway is type I and type II deiodinase activity (not CYP enzymes), this finding does not suggest a clinically meaningful pharmacokinetic interaction [6].

The 60-Minute Rule

Despite the low mineral content, any oral supplement can theoretically alter gastric pH or motility. The safest practice is to follow the same timing rule that applies to all supplements taken with levothyroxine: take levothyroxine first thing in the morning on an empty stomach, wait at least 30 to 60 minutes, then take rhodiola with or after breakfast. The American Thyroid Association (ATA) recommends this general separation window for all concurrent oral supplements [7].

Pharmacodynamic Considerations: Does Rhodiola Affect Thyroid Function Directly?

This is where the picture gets more complex. Rhodiola rosea contains bioactive compounds (rosavins, salidroside, tyrosol) that have been studied for effects on the hypothalamic-pituitary-adrenal (HPA) axis and, to a lesser degree, the hypothalamic-pituitary-thyroid (HPT) axis.

Animal Data on Thyroid Hormones

A 2006 study in Phytomedicine by Mannucci et al. Examined rhodiola's effects on thyroid tissue in rats. Animals given rhodiola extract at 20 mg/kg for 10 days showed a statistically significant increase in thyroid gland T3 content compared to controls [8]. The finding was not replicated in a human trial, and rodent thyroid physiology differs from human physiology in important ways (rats have a much higher metabolic rate per kilogram of body weight). Still, this observation raises the theoretical possibility that rhodiola could modestly influence peripheral T4-to-T3 conversion.

MAO Inhibition and Serotonergic Activity

Rhodiola's salidroside has demonstrated mild monoamine oxidase (MAO) inhibitory activity in vitro. A 2009 study in Phytomedicine measured IC50 values for MAO-B inhibition at concentrations achievable with standard oral dosing [9]. Classical MAO inhibitors (phenelzine, tranylcypromine) are not known to alter thyroid hormone levels directly, but they can amplify the cardiovascular effects of thyroid hormones, specifically the risk of tachycardia and hypertension, because both catecholamines and thyroid hormones increase cardiac beta-adrenergic sensitivity [10].

What This Means Clinically

For a person taking a stable dose of levothyroxine with a TSH in the target range (typically 0.5 to 2.5 mIU/L for most adults), adding rhodiola at standard doses (200 to 600 mg/day) is unlikely to cause a clinically detectable shift in thyroid function. The MAO-inhibitory potency of rhodiola is far weaker than that of prescription MAO inhibitors. The theoretical T3-boosting effect seen in rats has not been confirmed in humans. The practical risk is low but not zero.

Recommended Monitoring Protocol

If you and your prescriber decide to try rhodiola alongside levothyroxine, a simple monitoring schedule reduces risk to near zero.

Baseline and Follow-Up Labs

Before starting rhodiola, confirm your current TSH and free T4 levels are stable (two consecutive results in range, at least 6 weeks apart). After adding rhodiola, recheck TSH and free T4 at 6 to 8 weeks. If values remain within your target range, recheck once more at 6 months, then resume your usual annual thyroid panel schedule [7].

Symptoms to Watch For

Because rhodiola is a mild stimulant, overlapping adrenergic effects with thyroid hormone can occasionally produce:

• Resting heart rate above 90 bpm
• Insomnia or difficulty staying asleep
• Jitteriness, tremor, or anxiety
• Heart palpitations, especially within the first 2 weeks

If any of these appear after starting rhodiola, stop the supplement and recheck TSH before adjusting your levothyroxine dose. Adjusting levothyroxine in response to a supplement-induced symptom (rather than a confirmed TSH change) is a common prescribing error.

When to Avoid the Combination Entirely

Certain populations should not combine rhodiola with levothyroxine without specialist oversight:

• Patients with TSH suppressed below 0.1 mIU/L (subclinical or overt hyperthyroidism, thyroid cancer suppression therapy)
• Patients taking concurrent SSRIs or SNRIs (additive serotonergic effects with rhodiola's salidroside)
• Patients with atrial fibrillation or a history of supraventricular tachycardia
• Pregnant or breastfeeding women (rhodiola lacks human reproductive safety data) [11]

Rhodiola Dosing and Product Quality

Not all rhodiola products deliver consistent bioactive content. A 2019 ConsumerLab analysis found that 4 of 11 tested rhodiola supplements failed quality testing, with some containing less than 1% rosavins instead of the labeled 3% [12].

What to Look For

Choose an extract standardized to 3% rosavins and 1% salidroside. This is the composition used in the majority of published clinical trials, including the 2012 randomized trial by Olsson et al. (N=60) in Planta Medica that demonstrated fatigue reduction over 28 days [13]. Start at 200 mg once daily in the morning. Taking rhodiola in the afternoon or evening may worsen insomnia, a problem that compounds with the stimulatory effects of adequately dosed levothyroxine.

Dose Ceiling

Most clinical trials have used doses between 200 and 680 mg/day. Doses above 600 mg/day have not shown additional benefit in published trials and may increase the likelihood of adrenergic side effects [13]. For someone on levothyroxine, staying at or below 400 mg/day is a reasonable ceiling until more interaction data becomes available.

What If You Are Already Taking Both?

If you have been taking rhodiola and levothyroxine together for weeks or months without symptoms and your most recent TSH is in range, the combination is working for you. There is no reason to stop rhodiola based solely on theoretical concern. Continue your routine monitoring.

Steps to Confirm Stability

1. Verify your most recent TSH was drawn at least 6 weeks after you started rhodiola.
2. Confirm you are taking levothyroxine on an empty stomach, separated from rhodiola by at least 60 minutes.
3. If your TSH has not been checked since adding rhodiola, schedule a draw within the next 2 to 4 weeks.

How Rhodiola Compares to Other Adaptogens with Levothyroxine

Several adaptogens are commonly marketed for fatigue, and their interaction profiles with levothyroxine vary.

Ashwagandha: A Different Risk Profile

Ashwagandha (Withania somnifera) has a more direct interaction concern with levothyroxine than rhodiola does. A 2018 prospective study published in the Journal of the American Board of Family Medicine by Sharma et al. (N=50) found that ashwagandha 600 mg/day significantly increased serum T4 and T3 levels in subclinical hypothyroid patients over 8 weeks compared to placebo [14]. This means ashwagandha can independently alter the thyroid axis, potentially requiring a levothyroxine dose adjustment. Rhodiola has not demonstrated this effect in any human study.

Eleuthero and Schisandra

Eleuthero (Siberian ginseng) and schisandra have no documented interaction with levothyroxine in either animal or human studies. Like rhodiola, they carry a theoretical risk of additive stimulation but no evidence of direct thyroid-axis interference [2].

The Bottom Line for Patients and Prescribers

The rhodiola-levothyroxine combination carries no documented pharmacokinetic interaction and only a theoretical pharmacodynamic concern based on animal data and in vitro MAO inhibition. Separate the doses by 60 minutes, monitor TSH at 6 to 8 weeks, and watch for adrenergic symptoms. Patients on TSH-suppressive thyroid cancer therapy or concurrent serotonergic medications should avoid this combination without endocrinologist or oncologist approval. For everyone else, the data support cautious use with standard monitoring. The next TSH draw is the most useful safety check you can get.